covid19

How to analyse SARS-CoV-2 data with Shivom

covid19

The rapid emergence of COVID-19 across the world has led to massive mortality and morbidity. The genome sequencing of the coronavirus (SARS-CoV-2) can provide clues regarding how the virus has evolved and variants within the genome. In this 60 minute webinar, Shivom’s VP of Product explains the fundamentals of analysing SARS-Cov-2 data on our platform through a library of curated multi-omics pipelines.

About Shivom
Shivom provides 1-click access to genomic data and insights. The end-to-end cloud operating system enables computation and analysis to Omics data, accelerating drug discovery and delivering novel insights to personalised medicine. Users are able to gain easy access to genomic data and the ability to run various bioinformatics & AI tools in one environment.

Headquartered in London, UK, Shivom’s mission is to build the world’s largest genetic marketplace. Shivom’s ecosystem of partners and customers spans 10 countries including two active European pilot projects with H2020.

Shivom Social Channels:
Official Homepage: shivom.io
Twitter (English): @projectshivom
Youtube: Shivom’s Channel
Facebook: @projectshivom
Instagram: @projectshivom
Medium: Shivom Official
LinkedIn: @projectshivom

Recent Updates

View All